Hints and tips:
...Philip Dormitzer will this week join GSK as global head of vaccines research and development, leaving the company where he played an important role in the development of Pfizer’s Covid-19 vaccine, including...
...Speaking to the Financial Times, Philip Dormitzer, chief scientific officer at Pfizer, defended the company against suggestions it was pressing policymakers to roll out third doses of its vaccine, which...
...Read a transcript of this episode on FT.com https://www.ft.com/content/7a545b87-55eb-4dbd-b9a0-c80def4bdcf8 Pfizer’s chief scientific officer Philip Dormitzer denied that the company should have developed...
...Speaking to the Financial Times, Philip Dormitzer, chief scientific officer at Pfizer, defended the company against suggestions it was pressing policymakers to roll out third doses of its vaccine — which...
...Talking to the Financial Times, Philip Dormitzer, Pfizer’s chief scientific officer, dismissed criticism that the company is pushing the widespread administration of Covid-19 booster shots too aggressively...
...“The lowest hanging fruit is in viral vaccines because we have this clear proof of concept,” says Philip Dormitzer, chief scientific officer of Pfizer. “But we don’t think that’s the endpoint.”...
...GlaxoSmithKline has hired Philip Dormitzer as global head of vaccines research and development....
...But Pfizer’s Philip Dormitzer defended booster shots when he spoke to the FT recently....
International Edition